Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres

Introduction Factor XI (FXI) deficiency is the commonest of the rare bleeding disorders, affecting 2079 individuals in the United Kingdom. Treatment options for bleeding or surgery include antifibrinolytics, fresh frozen plasma or plasma‐derived (pd) FXI concentrates. There were a number of reports...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haemophilia : the official journal of the World Federation of Hemophilia 2015-07, Vol.21 (4), p.490-495
Hauptverfasser:	Batty, P., Honke, A., Bowles, L., Hart, D. P., Pasi, K. J., Uprichard, J., Austin, S. K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over bleeding Blood Loss, Surgical - prevention & control Child Drug Dosage Calculations factor XI Factor XI - adverse effects Factor XI - therapeutic use Factor XI Deficiency - drug therapy Factor XI Deficiency - pathology Female Hemostasis, Surgical Humans Male Middle Aged plasma-derived concentrate Retrospective Studies Risk surgery thrombosis Thrombosis - etiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!